Trial · NCT03720288
Acetazolamide in Patients With Acute Heart Failure
NCT03720288, Phase 3, Unknown, University of Sao Paulo General Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Acetazolamide in Patients With Acute Heart Failure. Trials, record NCT03720288. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03720288
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Acetazolamide in Patients With Acute Heart Failure
- NCT number
- NCT03720288
- Status
- Unknown
- Phases
- Phase 3
- Enrollment
- 90 participants, estimated
- Lead sponsor
- University of Sao Paulo General Hospital
- Conditions
- Heart Failure, Acute Heart Failure
- Interventions
- Acetazolamide, Placebo
- First posted
- 2018-10-25
- Last updated
- 2018-10-30
Source ClinicalTrials.gov
Registered outcomes22
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | diuresis and negative water balance | 72 hours | The comparison between groups for diuresis and negative water balance |
| Secondary | Number of cases with worsening of renal function | 72 hours | worsening of renal function (increase of 0.5 mg / dl or 25% increase in relation to admission creatinine) |
| Secondary | Number of cases with lowering of consciousness level | 72 hours | lowering of consciousness level |
| Secondary | Number of cases with circulatory assistance | 72 hours | need for mechanical circulatory assistance |
| Secondary | Number of cases with vasopressor | 72 hours | need for vasopressor or inotropic association |
| Secondary | Number of cases with orotracheal intubation | 72 hours | need for orotracheal intubation |
| Secondary | Number of cases with arrhythmia | 72 hours | occurrence of sustained ventricular arrhythmia |
| Secondary | Number of cases with acetazolamide side effects | 72 hours | need for suspension of acetazolamide due to side effects |
| Secondary | Number of cases of death | 72 hours | ocurrence of death |
| Secondary | Level of Base excess | 30 days | Comparison of all hemodynamic / metabolic parameters to be evaluated (base excess) |
1 to 10 of 22Source ClinicalTrials.gov
See all 22 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03720288
GET https://conductscience.org/api/trials/v1/NCT03720288/registered?page=2